Colin John Meyer, Chief Medical Officer at REATA PHARMACEUTICALS INC (RETA), bought 7,000 shares at $16.26 ($114K) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market purchase of $114k RETA by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| RETA | SELL | 2023-03-08 | $105K | — | Filing → |
| RETA | SELL | 2023-03-06 | $16.3M | — | Filing → |
| RETA | SELL | 2021-06-16 | $16.4M | — | Filing → |